Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Vifor Pharma AG (VIFN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Vifor Pharma historical data, for real-time data please try another search
166.15 +0.00    +0.00%
22/12 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Switzerland
ISIN:  CH0364749348 
VALOR:  36474934
  • Volume: 0
  • Bid/Ask: 166.15 / 166.20
  • Day's Range: 165.00 - 166.50
Vifor Pharma 166.15 +0.00 +0.00%

VIFN Balance Sheet

 
Featured here, the Balance Sheet for Vifor Pharma AG, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2021
31/12
2021
30/06
2020
31/12
2020
30/06
Total Current Assets 1878.6 1570 1609 1261.7
Cash and Short Term Investments 994.5 626.5 738.3 307.4
Cash - - - -
Cash & Equivalents 993.6 626.2 730 304.7
Short Term Investments 0.9 0.3 8.3 2.7
Total Receivables, Net 442.7 515.7 492.4 485.7
Accounts Receivables - Trade, Net 439.3 509.4 487.7 481.7
Total Inventory 347 397.4 339.8 420.2
Prepaid Expenses 19.3 30.4 38.4 48.4
Other Current Assets, Total 75.1 - 0.1 -
Total Assets 5099.6 4916.3 5211.7 4899.5
Property/Plant/Equipment, Total - Net 186.8 296.2 302.4 351.4
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 2386 2447.5 2454.5 2557.1
Long Term Investments 482.6 408 740.9 660.2
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 165.6 194.6 104.9 69.1
Other Assets, Total - - - -
Total Current Liabilities 981.3 530.8 544 548.6
Accounts Payable 163.1 122.6 162.1 140
Payable/Accrued - - - -
Accrued Expenses 203.6 269.7 249.1 308.3
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 486.6 21.7 23 14.3
Other Current liabilities, Total 128 116.8 109.8 86
Total Liabilities 1609.7 1545.1 1641.9 1606.2
Total Long Term Debt 117 594.1 608.6 620.9
Long Term Debt 81.9 550.2 552.8 565.5
Capital Lease Obligations 35.1 43.9 55.8 55.4
Deferred Income Tax 23.9 17.5 30.7 46.3
Minority Interest 479.2 391.8 447.8 379.5
Other Liabilities, Total 8.3 10.9 10.8 10.9
Total Equity 3489.9 3371.2 3569.8 3293.3
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.7 0.7 0.7 0.7
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 3750.2 3611.6 3863 3529.2
Treasury Stock - Common -9.8 -14.7 -19 -21.2
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) 0.5 -0.2 3.9 0.7
Other Equity, Total -251.7 -226.2 -278.8 -216.1
Total Liabilities & Shareholders' Equity 5099.6 4916.3 5211.7 4899.5
Total Common Shares Outstanding 64.89 64.86 64.86 64.89
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VIFN Comments

Write your thoughts about Vifor Pharma AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gold Trader
24Karat_skkkrt Jul 17, 2017 9:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All the way up
Gold Trader
24Karat_skkkrt Jul 17, 2017 9:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email